Kura Oncology, Inc. announced a private placement of 1,376,813 shares of its common stock at a price of $17.25 per share and pre paid warrants at a price of $17.2499 for the total gross proceeds of $150,000,000 on January 24, 2024. The pre paid warrant will be exercisable into common shares at a price of $0.0001. The private placement is expected to close on or about January 26, 2024, subject to customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.54 USD | -2.49% | +1.31% | +42.87% |
May. 02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.87% | 1.57B | |
+2.93% | 108B | |
-0.44% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology, Inc. announced that it expects to receive $150 million in funding from EcoR1 Capital, LLC